ZNF701
gene geneOn this page
Also known as FLJ10891
Summary
ZNF701 (zinc finger protein 701, HGNC:25597) is a protein-coding gene on chromosome 19q13.41, encoding Zinc finger protein 701 (Q9NV72). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.
Source: NCBI Gene 55762 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 121 total — 1 pathogenic
- MANE Select transcript:
NM_018260
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:25597 |
| Approved symbol | ZNF701 |
| Name | zinc finger protein 701 |
| Location | 19q13.41 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ10891 |
| Ensembl gene | ENSG00000167562 |
| Ensembl biotype | protein_coding |
| Entrez | 55762 |
Gene structure
Transcript identifiers
Ensembl transcripts: 19 — 12 protein_coding, 5 protein_coding_CDS_not_defined, 2 nonsense_mediated_decay
ENST00000301093, ENST00000391785, ENST00000478039, ENST00000593941, ENST00000596514, ENST00000597158, ENST00000753349, ENST00000753350, ENST00000753351, ENST00000850979, ENST00000850980, ENST00000906409, ENST00000906410, ENST00000906411, ENST00000937256, ENST00000937257, ENST00000937258, ENST00000937259, ENST00000971181
RefSeq mRNA: 7 — MANE Select: NM_018260
NM_001172655, NM_001433681, NM_001433682, NM_001433683, NM_001433684, NM_001433685, NM_018260
CCDS: CCDS33092, CCDS54311
Canonical transcript exons
ENST00000391785 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002234009 | 52582202 | 52587174 |
| ENSE00002519915 | 52575895 | 52576021 |
| ENSE00003171682 | 52570287 | 52570330 |
| ENSE00004283129 | 52574077 | 52574162 |
Expression profiles
Bgee: expression breadth ubiquitous, 204 present calls, max score 88.79.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 5.3754 / max 72.2144, expressed in 1505 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 177312 | 5.3754 | 1505 |
Top tissues by expression
274 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| buccal mucosa cell | CL:0002336 | 88.79 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 87.45 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 85.49 | gold quality |
| amniotic fluid | UBERON:0000173 | 85.39 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 84.82 | gold quality |
| tendon | UBERON:0000043 | 83.95 | gold quality |
| calcaneal tendon | UBERON:0003701 | 83.02 | gold quality |
| granulocyte | CL:0000094 | 80.45 | gold quality |
| leukocyte | CL:0000738 | 79.43 | gold quality |
| monocyte | CL:0000576 | 79.36 | gold quality |
| mononuclear cell | CL:0000842 | 79.09 | gold quality |
| colonic epithelium | UBERON:0000397 | 79.02 | gold quality |
| right uterine tube | UBERON:0001302 | 78.96 | gold quality |
| sural nerve | UBERON:0015488 | 77.90 | gold quality |
| adrenal tissue | UBERON:0018303 | 77.79 | gold quality |
| rectum | UBERON:0001052 | 77.68 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 77.47 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 76.80 | gold quality |
| apex of heart | UBERON:0002098 | 76.67 | gold quality |
| endothelial cell | CL:0000115 | 76.65 | silver quality |
| islet of Langerhans | UBERON:0000006 | 76.60 | gold quality |
| stromal cell of endometrium | CL:0002255 | 76.50 | gold quality |
| thyroid gland | UBERON:0002046 | 76.50 | gold quality |
| blood | UBERON:0000178 | 76.38 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 76.13 | gold quality |
| mucosa of stomach | UBERON:0001199 | 76.06 | gold quality |
| pancreatic ductal cell | CL:0002079 | 75.78 | silver quality |
| ganglionic eminence | UBERON:0004023 | 75.78 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 75.78 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 75.75 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 3.95 |
Regulation
Is transcription factor: yes
JASPAR motifs
| Motif | Name | Family |
|---|---|---|
| MA1987.1 | ZNF701 | More than 3 adjacent zinc fingers |
| MA1987.2 | ZNF701 | More than 3 adjacent zinc fingers |
JASPAR matrix evidence (PMIDs): PMID:22955616
miRNA regulators (miRDB)
108 targeting ZNF701, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6833-3P | 100.00 | 70.63 | 3197 |
| HSA-MIR-3925-3P | 100.00 | 69.95 | 1237 |
| HSA-MIR-4768-5P | 100.00 | 69.49 | 2861 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-3064-3P | 100.00 | 70.09 | 1254 |
| HSA-MIR-6873-3P | 100.00 | 71.42 | 2626 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-4803 | 99.98 | 71.99 | 3117 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-548AA | 99.96 | 70.64 | 3753 |
| HSA-MIR-548AP-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-548T-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-548AJ-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-548X-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-23A-3P | 99.95 | 74.24 | 3163 |
| HSA-MIR-23B-3P | 99.95 | 74.24 | 3163 |
| HSA-MIR-23C | 99.95 | 73.92 | 3192 |
| HSA-MIR-6845-3P | 99.94 | 66.88 | 1439 |
| HSA-MIR-548J-3P | 99.94 | 72.61 | 4881 |
| HSA-MIR-548AE-3P | 99.93 | 72.66 | 4867 |
| HSA-MIR-548AH-3P | 99.93 | 72.54 | 4872 |
| HSA-MIR-548AM-3P | 99.93 | 72.54 | 4872 |
| HSA-MIR-548AQ-3P | 99.93 | 72.66 | 4867 |
| HSA-MIR-450B-5P | 99.92 | 71.48 | 3175 |
| HSA-MIR-6809-3P | 99.91 | 71.45 | 3814 |
| HSA-MIR-548D-3P | 99.87 | 70.67 | 4362 |
| HSA-MIR-6124 | 99.87 | 69.78 | 3551 |
| HSA-MIR-548BB-3P | 99.86 | 70.58 | 4354 |
Literature-anchored findings (GeneRIF, showing 1)
- Mediating effect of genome-wide DNA methylation on suicidal ideation induced by perceived stress. (PMID:34050117)
Cross-species orthologs
0 orthologs
Paralogs (11): ZNF761 (ENSG00000160336), ZNF816 (ENSG00000180257), ZNF766 (ENSG00000196214), ZNF765 (ENSG00000196417), ZNF860 (ENSG00000197385), ZNF813 (ENSG00000198346), ZNF525 (ENSG00000203326), ZNF468 (ENSG00000204604), ZNF888 (ENSG00000213793), ZNF578 (ENSG00000258405), (ENSG00000269825)
Protein
Protein identifiers
Zinc finger protein 701 — Q9NV72 (reviewed: Q9NV72)
All UniProt accessions (3): Q9NV72, M0R085, M0R327
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9NV72-1 | 1 | yes |
| Q9NV72-2 | 2 |
RefSeq proteins (7): NP_001166126, NP_001420610, NP_001420611, NP_001420612, NP_001420613, NP_001420614, NP_060730* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096, PF01352
UniProt features (22 total): zinc finger region 9, sequence variant 7, chain 1, domain 1, region of interest 1, compositionally biased region 1, cross-link 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9NV72-F1 | 57.65 | 0.12 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 271
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 66 (showing top):
BLALOCK_ALZHEIMERS_DISEASE_UP, GEORGES_TARGETS_OF_MIR192_AND_MIR215, GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, ASH1L_TARGET_GENES, CBX5_TARGET_GENES, CBX7_TARGET_GENES, E2F2_TARGET_GENES, ELF2_TARGET_GENES, H1_6_TARGET_GENES, KAT5_TARGET_GENES, ZNF274_TARGET_GENES, ZNF350_TARGET_GENES
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (5): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
490 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF701 | Q6GMV1 | Q6GMV1 | 447 |
| ZNF701 | TRIM61 | Q5EBN2 | 440 |
| ZNF701 | CYB561D1 | Q8N8Q1 | 411 |
| ZNF701 | TAS2R30 | P59541 | 404 |
| ZNF701 | OR8U1 | Q8NH10 | 400 |
| ZNF701 | HRCT1 | Q6UXD1 | 399 |
| ZNF701 | DQX1 | Q8TE96 | 398 |
| ZNF701 | DNHD1 | Q96M86 | 371 |
| ZNF701 | DCAF4L2 | Q8NA75 | 370 |
| ZNF701 | TOP6BL | Q8N6T0 | 369 |
| ZNF701 | SNX11 | Q9Y5W9 | 365 |
| ZNF701 | ZER1 | Q7Z7L7 | 348 |
| ZNF701 | SLFN14 | P0C7P3 | 348 |
| ZNF701 | ZYG11B | Q9C0D3 | 326 |
| ZNF701 | UTP3 | Q9NQZ2 | 323 |
IntAct
8 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TRIM28 | ZNF320 | psi-mi:“MI:0914”(association) | 0.530 |
| TRIM28 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| GPATCH4 | NOP56 | psi-mi:“MI:0914”(association) | 0.350 |
| M | psi-mi:“MI:0914”(association) | 0.350 | |
| NVL | psi-mi:“MI:0914”(association) | 0.350 | |
| RBM4B | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (18): ZNF701 (Affinity Capture-MS), ZNF701 (Affinity Capture-MS), ZNF701 (Affinity Capture-MS), ZNF701 (Affinity Capture-MS), ZNF701 (Affinity Capture-MS), ZNF701 (Affinity Capture-MS), ZYG11B (Protein-peptide), ZNF701 (Protein-peptide), ZNF701 (Protein-peptide), ZNF701 (Co-crystal Structure), ZNF701 (Affinity Capture-MS), ZER1 (Affinity Capture-Western), ZNF701 (Protein-peptide), ZNF701 (Protein-peptide), ZNF701 (Co-crystal Structure)
ESM2 similar proteins: A0A1W2PQL4, A0JPL0, A2RRD8, A6NHJ4, A6NP11, B4DX44, O75346, O95780, P0CB33, P21506, P51508, P52738, Q0D2J5, Q0VGE8, Q12901, Q13360, Q14593, Q15973, Q2M218, Q2M3X9, Q2VY69, Q3SXZ3, Q5HY98, Q5RCJ2, Q5VIY5, Q6J6I6, Q7L2R6, Q86XU0, Q86Y25, Q8IW36, Q8IYN0, Q8IYX0, Q8N782, Q8N883, Q8N9Z0, Q8NDP4, Q95K49, Q969W8, Q96H40, Q96N58
Diamond homologs: A0A1W2PQL4, A2RRD8, A2VDQ7, A6NHJ4, A6NK75, A6NN14, A6NNF4, A6NP11, B4DX44, B4DXR9, E9PW05, O14628, O43345, O75290, O75346, O75373, O75820, P0CB33, P0CJ79, P0DKX0, P10755, P17032, P17035, P52738, Q02386, Q03923, Q03936, Q05481, Q08AN1, Q09FC8, Q0VGE8, Q14586, Q14593, Q147U1, Q15928, Q3MIS6, Q3SXZ3, Q494X3, Q4R6C2, Q5HY98
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
121 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 105 |
| Likely benign | 7 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 59127 | GRCh38/hg38 19q13.41-13.43(chr19:51141518-58539965)x3 | Pathogenic |
SpliceAI
545 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:52570327:GGCG:G | donor_gain | 1.0000 |
| 19:52570328:GCGG:G | donor_gain | 1.0000 |
| 19:52570329:CGG:C | donor_loss | 1.0000 |
| 19:52570331:G:GG | donor_gain | 1.0000 |
| 19:52575891:TCA:T | acceptor_loss | 1.0000 |
| 19:52575892:CA:C | acceptor_loss | 1.0000 |
| 19:52575893:A:AG | acceptor_gain | 1.0000 |
| 19:52575893:A:AT | acceptor_loss | 1.0000 |
| 19:52575893:AG:A | acceptor_gain | 1.0000 |
| 19:52575894:G:GG | acceptor_gain | 1.0000 |
| 19:52575894:GG:G | acceptor_gain | 1.0000 |
| 19:52575894:GGGT:G | acceptor_gain | 1.0000 |
| 19:52575894:GGGTC:G | acceptor_gain | 1.0000 |
| 19:52582191:A:AG | acceptor_gain | 1.0000 |
| 19:52582193:A:AG | acceptor_gain | 1.0000 |
| 19:52582194:T:G | acceptor_gain | 1.0000 |
| 19:52582197:TGTAG:T | acceptor_loss | 1.0000 |
| 19:52582200:A:AG | acceptor_gain | 1.0000 |
| 19:52582200:AGAT:A | acceptor_loss | 1.0000 |
| 19:52582201:G:GA | acceptor_gain | 1.0000 |
| 19:52582201:GA:G | acceptor_gain | 1.0000 |
| 19:52582201:GAT:G | acceptor_gain | 1.0000 |
| 19:52582201:GATA:G | acceptor_gain | 1.0000 |
| 19:52582201:GATAC:G | acceptor_gain | 1.0000 |
| 19:52570326:CGGCG:C | donor_gain | 0.9900 |
| 19:52570327:GGCGG:G | donor_gain | 0.9900 |
| 19:52570328:GCG:G | donor_gain | 0.9900 |
| 19:52570329:CG:C | donor_gain | 0.9900 |
| 19:52570330:GG:G | donor_gain | 0.9900 |
| 19:52570332:T:A | donor_loss | 0.9900 |
AlphaMissense
3112 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:52583146:T:C | F429L | 0.995 |
| 19:52583148:C:A | F429L | 0.995 |
| 19:52583148:C:G | F429L | 0.995 |
| 19:52583398:T:C | F513L | 0.995 |
| 19:52583400:T:A | F513L | 0.995 |
| 19:52583400:T:G | F513L | 0.995 |
| 19:52583062:T:C | F401L | 0.994 |
| 19:52583064:C:A | F401L | 0.994 |
| 19:52583064:C:G | F401L | 0.994 |
| 19:52582978:T:C | F373L | 0.993 |
| 19:52582980:T:A | F373L | 0.993 |
| 19:52582980:T:G | F373L | 0.993 |
| 19:52583230:T:C | F457L | 0.993 |
| 19:52583232:T:A | F457L | 0.993 |
| 19:52583232:T:G | F457L | 0.993 |
| 19:52583314:T:C | F485L | 0.993 |
| 19:52583316:T:A | F485L | 0.993 |
| 19:52583316:T:G | F485L | 0.993 |
| 19:52582894:T:C | F345L | 0.992 |
| 19:52582896:C:A | F345L | 0.992 |
| 19:52582896:C:G | F345L | 0.992 |
| 19:52583175:T:A | H438Q | 0.987 |
| 19:52583175:T:G | H438Q | 0.987 |
| 19:52583405:G:C | R515P | 0.985 |
| 19:52575928:T:C | F83L | 0.984 |
| 19:52575930:C:A | F83L | 0.984 |
| 19:52575930:C:G | F83L | 0.984 |
| 19:52583069:G:C | R403P | 0.982 |
| 19:52583103:C:A | H414Q | 0.982 |
| 19:52583103:C:G | H414Q | 0.982 |
dbSNP variants (sampled 300 via entrez): RS1000079959 (19:52600642 A>C,G), RS1000152012 (19:52570141 G>A,C), RS1000176005 (19:52588461 T>A), RS1000278609 (19:52584333 G>A), RS1000331006 (19:52595390 C>G), RS1000424747 (19:52582040 C>G), RS1000447071 (19:52595640 G>T), RS1000473739 (19:52589059 T>C), RS1000538513 (19:52583487 C>G,T), RS1000609465 (19:52585165 G>A), RS1000623195 (19:52578147 G>A), RS1000766241 (19:52588785 C>T), RS1000821025 (19:52589572 C>A,T), RS1000823831 (19:52570845 A>G), RS1000868619 (19:52580692 C>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST003501_3 | Asparaginase-induced acute pancreatitis in acute lymphoblastic leukemia (onset time) | 2.000000e-06 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:1001507 | asparaginase-induced acute pancreatitis |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
22 total (human), top 22 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | decreases expression, increases expression | 3 |
| Benzo(a)pyrene | increases expression, increases methylation, decreases reaction | 2 |
| Cadmium Chloride | decreases expression, increases abundance, increases expression | 2 |
| GSK-J4 | decreases expression | 1 |
| chlorophyllin | increases expression, decreases reaction | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | increases expression | 1 |
| butyraldehyde | increases expression | 1 |
| potassium chromate(VI) | increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| Temozolomide | increases expression | 1 |
| Air Pollutants | affects expression, increases abundance | 1 |
| Cadmium | increases abundance, increases expression | 1 |
| Hydralazine | affects cotreatment, increases expression | 1 |
| Ozone | affects expression, increases abundance | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Valproic Acid | affects cotreatment, increases expression | 1 |
| Vanadates | decreases expression | 1 |
| Antirheumatic Agents | decreases expression | 1 |
| Copper Sulfate | increases expression | 1 |
| Lactic Acid | increases expression | 1 |
| Acrylamide | increases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_XW77 | HEK293 eGFP-ZNF701 | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.